comparemela.com

Latest Breaking News On - Austin macintyre - Page 1 : comparemela.com

Universal PropTech Confirms Launch of ISBRG Corp s SpotLight-19(C) Clinical Trial and New R&D Funding Assistance

Universal PropTech Confirms Launch of ISBRG Corp s SpotLight-19(C) Clinical Trial and New R&D Funding Assistance
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Universal PropTech Confirms Launch of ISBRG Corp s SpotLight-19 Clinical Trial and New R&D Funding Assistance

Universal Proptech Inc. is pleased to announce that ISBRG Corp., in which UPI owns a minority interest announced progress related to the ongoing development of its COVID-19 diagnostic device – SpotLight-19©. In addition to ISBRG’s receipt of a Health Canada Investigational Testing Authorization and the start of ISBRG’s clinical trial, ISBRG has announced the addition of two new Advisory Board members, as well as … Universal Proptech Inc. (TSXV: UPI) (OTCQB: UPIPF) (FSE: 8LH) (“UPI” or the “Company”) is pleased to announce that ISBRG Corp., in which UPI owns a minority interest (see press release dated February 18, 2021), announced progress related to the ongoing development of its COVID-19 diagnostic device – SpotLight-19©. In addition to ISBRG’s receipt of a Health Canada Investigational Testing Authorization (ITA), and the start of ISBRG’s clinical trial, ISBRG has announced the addition of two new Advisory Board members, as well as the receipt of advisory

Universal PropTech Inc Provides Update on SpotLight-19(C) - Designed to Detect COVID-19 in Under 20 Seconds and at a Cost of Approximately $1 Per Test

Universal PropTech Inc. Provides Update on SpotLight-19(C) - Designed to Detect COVID-19 in Under 20 Seconds and at a Cost of Approximately $1 Per Test UPI or the ISBRG ) has posted a number of updates on their website (www.isbrgcorp.com) regarding their SpotLight-19 © Technology including updating the expected COVID-19 detection time to under 20 seconds, at an approximate cost of $1 per COVID-19 test, an expanded list of solutions, and adding an additional advisor to the Advisory Board. ISBRG s SpotLight-19© technology leverages advancements in optics and artificial intelligence to define a state of COVID-19 infection. SpotLight-19© (which upon testing to establish specificity and sensitivity ISBRG intends to submit for regulatory approval) is designed to screen for a unique infectious state - within 20 seconds of scanning a fingertip with light. ISBRG is undertaking trials to determine SpotLight-19© s efficacy in detecting COVID-19, and if proven effective, will be

Universal PropTech Inc Provides Update on SpotLight-19 - Designed to Detect COVID-19 in Under 20 Seconds and at a Cost of Approximately $1 Per Test

Universal PropTech Inc Provides Update on SpotLight-19 - Designed to Detect COVID-19 in Under 20 Seconds and at a Cost of Approximately $1 Per Test
investingnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investingnews.com Daily Mail and Mail on Sunday newspapers.

Universal PropTech Inc Invests in and Secures defined Agency Rights for ISBRG Corp s SpotLight-19(C) Technology Designed to Detect Covid-19 Non-Invasively in Under One Minute

Universal PropTech Inc. Invests in and Secures defined Agency Rights for ISBRG Corp. s SpotLight-19(C) Technology Designed to Detect Covid-19 Non-Invasively in Under One Minute UPI or the ISBRG ) for a minority interest, and secured agency rights to their SpotLight-19 © Technology. ISBRG is a data analytics company which has developed the SpotLight technology platform designed to generate comprehensive health care data non-invasively within seconds at a nominal incremental cost per test. SpotLight-19 © is non-invasive, and ISBRG is undertaking trials to determine efficacy in detecting Covid-19. In addition to its minority investment, UPI will act as the exclusive sales agent for the SpotLight-19

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.